Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis;Holter glycémique et dépistage du diabète chez l'enfant atteint de mucoviscidose

Archives de Pediatrie

Volumn 16, Issue 12, 2009, Pages 1540-1546

  Khammar, A ^a   Stremler, N ^a   Dubus, J C ^a   Gross, G ^a   Sarles, J ^a   Reynaud, R ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEALTH STATUS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; LONGEVITY; LUNG FUNCTION; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS INSUFFICIENCY; PREVALENCE; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; BODY MASS INDEX; CHILD; CIRCADIAN RHYTHM; CYSTIC FIBROSIS; DIABETES MELLITUS; FRANCE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MASS SCREENING; MONITORING, PHYSIOLOGIC; PREVALENCE; REFERENCE VALUES; TIME FACTORS;

EID: 70549096073     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2009.09.007     Document Type: Article

References (23)

1. Durieu I., and Nove Josserand R. Cystic fibrosis in 2008. Rev Med Interne 29 (2008) 901-907
2. Costa M., Potvin S., Berthiaume Y., et al. Diabetes: A major comorbidity of cystic fibrosis. Diabetes Metab 31 (2005) 221-232
3. Turck D. Quelle influence de l'état nutritionnel sur l'évolution de la mucoviscidose ? Aspect physiopathologique des troubles nutritionnels au cours de la mucoviscidose. Arch Pediatr 10 Suppl. 3 (2003) 413-420
4. Bismuth E., Laborde K., Taupin P., et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 152 (2008) 540-545
5. Marshall B.C., Butler S.M., Stoddard M., et al. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 146 (2005) 681-687
6. Sims E.J., Green M.W., and Mehta A. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 28 (2005) 1581-1587
7. Zamora M.R., Edwards L.B., Weill D., et al. Impact of cystic fibrosis-related diabetes on lung transplant outcomes. J Heart Lung Transplant 23 Suppl. 2 (2004) 93
8. Dobson L., Hattersley A.T., Tiley S., et al. Clinical improvement in cystic fibrosis with early insulin. Arch Dis Child 87 (2002) 430-431
9. Franzese A., Spagnuolo M.I., Sepe A., et al. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes?. Diabetes Care 28 (2005) 2333
10. Rolon M.A., Benali K., Munck A., et al. Cystic fibrosis-related diabetes mellitus: Clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 90 (2001) 860-867
11. Andersen H.U., Lanng S., Pressler T., et al. Cystic fibrosis-related diabetes: The presence of microvascular diabetes complications. Diabetes Care 29 (2006) 2660-2663
12. Schwarzenberg S.J., Thomas W., Olsen T.W., et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30 (2007) 1056-1061
13. Solomon M.P., Wilson D.C., Corey M., et al. Glucose intolerance in children with cystic fibrosis. J Pediatr 142 (2003) 128-132
14. Mosnier-Pudar H. Quelles stratégies diagnostiques et thérapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose ? Diabète de la mucoviscidose : physiopathologie et critères diagnostiques des troubles du métabolisme glucidique. Arch Pediatr 10 Suppl. 3 (2003) 462-468
15. Mueller-Brandes C., Holl R.W., Nastoll M.E., et al. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 25 (2005) 715-717
16. Bretones P. Stratégies diagnostiques et thérapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose. Arch Pediatr 10 Suppl. 3 (2003) 475-486
17. Kaufman R., Gibson C., Halvorson M., et al. A pilot study of the continuous glucose monitoring system: Clinical decision and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 24 (2001) 2030-2034
18. Dobson L., Sheldon C.D., and Hattersley A.T. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 26 (2003) 1940-1941
19. Dobson L., Sheldon C.D., and Hattersley A.T. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 21 (2004) 691-696
20. Costa M., Potvin S., Hammana I., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 6 (2007) 376-383
21. Rolland-Cachera M.F., Cole T.J., Sempé M., et al. Body mass index variations : Centiles from birth to 87 years. Eur J Clin Nutr 45 (1991) 13-21
22. Moreau F., Weiller M.A., Rosner V., et al. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 40 (2008) 502-506
23. Franzese A., Valerio G., Buono P., et al. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. J Clin Pediatr Endocrinol Metab 2 (2008) 109-116